[1] 王振刚. 病情改善抗风湿药物的肝损害. 中国医刊,2013,48:105-106. [2] 中华医学会消化病学分会肝胆疾病协作组. 急性药物性肝损伤诊治建议(草案).中华消化杂志, 2007,27:765-767. [3] Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol, 2014, 109: 950-966. [4] 林艳,唐蕾,黄峰. 抗类风湿药物活性研究进展. 亚太传统医药,2013,9:70-72. [5] 齐海宇,段婷. 双环醇在抗风湿药物导致肝损伤中的临床研究. 胃肠病学和肝病学杂志,2013,22:1147-1150. [6] Daly AK. Drug-induced liver injury: past, present and future. Pharmacogenomics, 2010,11: 607-611. [7] Monshi MM, Faulkner L, Gibson A, et al. Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury. Hepatology, 2013,57: 727-739. [8] 周璐,王邦茂. 药物性肝损伤的免疫学研究进展. 胃肠病学,2014,19:641-643. [9] 任东东,邓存良. 药物性肝损伤的研究进展. 西南军医,2014,16:670-672. |